The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO MAP 2022 | Air pollution induced non-small cell lung cancer
Emilia Lim, PhD, UCL, London, UK, discusses an investigation into air pollution induced non-small cell lung cancer, revealing possible methods of cancer prevention. At least 15% of cases of lung cancers occur in never-smokers. Instead of inducing a multitude of mutations leading to cancer it was hypothesized that air pollution may act on pre-existing mutations in nascent clones. The hypothesis was tested through a series of comprehensive human and animal experiments. Mice with KRAS and EGFR mutations were exposed to air pollution, which demonstrated an increase in tumors and tumor size in a dose-dependent manner. Additionally, pre-existing mutations were found in 16-19% of healthy human lung tissue samples investigated. The number of mutations found in lung tissue samples were positively correlated with age, suggesting mutations are a natural process of aging, as opposed to a carcinogen. This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
